Billionaire Boys Club Member Forum (BBCMF)

[mick]

11:52AM Pfizer and sanofi-aventis notified that FDA is extending its original review period for Exubera (PFE) 21.20 +0.10:PFE and sanofi-aventis (SNY) said that the FDA has notified the cos that it is extending its original review period for Exubera by three months to review additional technical chemistry data submitted by the companies. In September, an FDA Advisory Committee recommended approval of Exubera for the treatment of adults with type 1 and type 2 diabetes. FDA is not obligated to follow the Advisory Committee's recommendation, but usually does so. PFE and sanofi-aventis continue to work closely with the FDA so that this important medicine can be made available for patients.